臨床試験支援サービスの世界市場：相別、サービス別、スポンサー別、地域別、機会、予測、2018年～2032年

世界の臨床試験支援サービスの市場規模は、2025年～2032年の予測期間中に8.16%のCAGRで拡大し、2024年の365億6,000万米ドルから2032年には684億9,000万米ドルに成長すると予測されています。臨床試験支援サービス市場は、疾病の蔓延、臨床試験の増加、医薬品をより迅速に市場に投入したいという官民両部門の需要に牽引され、継続的に進化しています。臨床試験デザインへの柔軟なアプローチ、患者中心の臨床試験、分散型、ハイブリッド型、遠隔医療戦略などの利用が増加しています。さらに、研究やヘルスケアへの投資に対する政府の支援政策やデジタルインフラの改善により、臨床研究の効率が向上し、世界各地の治験施設における専門的なサポートサービスへの需要が高まっています。

市場の成長は、世界のライフサイエンストップ企業による研究開発投資に起因しています。この投資の目的は、組織の業務負担を最小限に抑え、臨床試験の効率を高めながら、医薬品開発のスピードを上げることです。サービスプロバイダーはまた、新しい技術（人工知能、臨床試験管理システム（CTMS）、遠隔モニタリングなど）を活用し、臨床試験の成果を向上させています。

例えば、2025年2月、Wonju Severance Christian HospitalとNovotech Pty Ltdは、臨床試験の件数を増やすために協力する覚書に調印しました。両者の専門知識を組み合わせることで、質の高い効率的な臨床試験に対する需要の高まりに対応し、臨床研究と医療サービスの向上を支援する手段を手にすることができます。

当レポートでは、世界の臨床試験支援サービス市場について調査し、市場の概要とともに、相別、サービス別、スポンサー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 世界の臨床試験支援サービス市場の見通し、2018年～2032年

• 市場規模分析と予測
• 市場シェア分析と予測
  • 相別
    • 第I相
    • 第II相
    • 第III相
    • 第IV相
  • サービス別
    • 臨床試験サイト管理
    • 被験者募集管理
    • データ管理
    • 管理スタッフ
    • IRB
    • その他
  • スポンサー別
    • 医療機器企業
    • 製薬会社およびバイオ医薬品会社
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ
  • 企業別市場シェア分析（上位5社およびその他- 金額別、2024年）
• 2024年の市場マップ分析

第6章 北米の臨床試験支援サービス市場の見通し、2018年～2032年

• 市場規模分析と予測
• 市場シェア分析と予測
• 国別市場評価
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の臨床試験支援サービス市場の見通し、2018年～2032年

• ドイツ
• フランス
• イタリア
• 英国
• ロシア
• オランダ
• スペイン
• トルコ
• ポーランド

第8章 アジア太平洋の臨床試験支援サービス市場の見通し、2018年～2032年

• インド
• 中国
• 日本
• オーストラリア
• ベトナム
• 韓国
• インドネシア
• フィリピン

第9章 南米の臨床試験支援サービス市場の見通し、2018年～2032年

• ブラジル
• アルゼンチン

第10章 中東・アフリカの臨床試験支援サービス市場の見通し、2018年～2032年

• サウジアラビア
• アラブ首長国連邦
• 南アフリカ

第11章 需要供給分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

• 市場の促進要因
• 市場の課題

第16章 市場動向と発展

第17章 規制状況とイノベーション

第18章 ケーススタディ

第19章 競合情勢

• 市場リーダートップ5の競合マトリックス
• 参入企業トップ5のSWOT分析
• 市場の主要企業トップ10の情勢
  • Charles River Laboratories International, Inc.
  • IQVIA Holdings Inc.
  • WuXi AppTec Co., Ltd.
  • Eurofins Scientific Limited
  • ICON plc
  • Syneos Health, Inc.
  • Parexel International (MA) Corporation
  • Laboratory Corporation of America Holdings
  • Novo Nordisk A/S
  • Thermo Fisher Scientific Inc. (PPD, Inc.)

第20章 戦略的提言

第21章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 2. Global Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 3. Global Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 4. Global Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 5. Global Clinical Trial Support Services Market Share (%), By Region, 2018-2032F
• Figure 6. North America Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 7. North America Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 8. North America Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 9. North America Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 10. North America Clinical Trial Support Services Market Share (%), By Country, 2018-2032F
• Figure 11. United States Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 12. United States Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 13. United States Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 14. United States Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 15. Canada Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 16. Canada Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 17. Canada Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 18. Canada Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 19. Mexico Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 20. Mexico Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 21. Mexico Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 22. Mexico Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 23. Europe Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 24. Europe Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 25. Europe Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 26. Europe Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 27. Europe Clinical Trial Support Services Market Share (%), By Country, 2018-2032F
• Figure 28. Germany Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 29. Germany Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 30. Germany Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 31. Germany Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 32. France Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 33. France Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 34. France Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 35. France Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 36. Italy Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 37. Italy Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 38. Italy Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 39. Italy Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 40. United Kingdom Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 41. United Kingdom Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 42. United Kingdom Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 43. United Kingdom Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 44. Russia Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 45. Russia Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 46. Russia Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 47. Russia Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 48. Netherlands Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 49. Netherlands Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 50. Netherlands Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 51. Netherlands Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 52. Spain Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 53. Spain Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 54. Spain Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 55. Spain Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 56. Turkey Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 57. Turkey Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 58. Turkey Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 59. Turkey Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 60. Poland Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 61. Poland Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 62. Poland Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 63. Poland Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 64. South America Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 65. South America Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 66. South America Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 67. South America Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 68. South America Clinical Trial Support Services Market Share (%), By Country, 2018-2032F
• Figure 69. Brazil Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 70. Brazil Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 71. Brazil Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 72. Brazil Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 73. Argentina Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 74. Argentina Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 75. Argentina Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 76. Argentina Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 77. Asia-Pacific Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 78. Asia-Pacific Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 79. Asia-Pacific Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 80. Asia-Pacific Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 81. Asia-Pacific Clinical Trial Support Services Market Share (%), By Country, 2018-2032F
• Figure 82. India Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 83. India Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 84. India Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 85. India Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 86. China Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 87. China Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 88. China Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 89. China Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 90. Japan Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 91. Japan Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 92. Japan Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 93. Japan Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 94. Australia Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 95. Australia Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 96. Australia Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 97. Australia Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 98. Vietnam Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 99. Vietnam Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 100. Vietnam Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 101. Vietnam Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 102. South Korea Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 103. South Korea Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 104. South Korea Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 105. South Korea Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 106. Indonesia Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 107. Indonesia Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 108. Indonesia Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 109. Indonesia Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 110. Philippines Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 111. Philippines Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 112. Philippines Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 113. Philippines Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 114. Middle East & Africa Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 115. Middle East & Africa Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 116. Middle East & Africa Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 117. Middle East & Africa Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 118. Middle East & Africa Clinical Trial Support Services Market Share (%), By Country, 2018-2032F
• Figure 119. Saudi Arabia Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 120. Saudi Arabia Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 121. Saudi Arabia Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 122. Saudi Arabia Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 123. UAE Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 124. UAE Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 125. UAE Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 126. UAE Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 127. South Africa Clinical Trial Support Services Market, By Value, In USD Billion, 2018-2032F
• Figure 128. South Africa Clinical Trial Support Services Market Share (%), By Phase, 2018-2032F
• Figure 129. South Africa Clinical Trial Support Services Market Share (%), By Service, 2018-2032F
• Figure 130. South Africa Clinical Trial Support Services Market Share (%), By Sponsor, 2018-2032F
• Figure 131. By Phase Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 132. By Service Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 133. By Sponsor Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024

Global clinical trial support services market is projected to witness a CAGR of 8.16% during the forecast period 2025-2032, growing from USD 36.56 billion in 2024 to USD 68.49 billion in 2032. The market for clinical trial support services is continuously evolving, driven by the increasing prevalence of diseases, the rise in clinical trials, and the demand from both the public and private sectors to bring drugs to market more quickly. The increasingly flexible approaches to trial design, patient-centric trialing and the use of decentralized, hybrid and telehealth strategies for study. Furthermore, supportive government policies for research and investment in healthcare, as well as improved digital infrastructure, are enhancing clinical research efficiency and boosting the demand for specialized support services across global trial sites.

Growth in the market stems from R&D investments by top life science companies worldwide. The goal of the investments is to elevate the speed of drug development while minimizing operational burdens on the organization and increasing efficiency in clinical trials. The service providers are also leveraging new technologies (including artificial intelligence, clinical trial management systems (CTMS), and remote monitoring) to improve trial outcomes.

For instance, in February 2025, Wonju Severance Christian Hospital and Novotech Pty Ltd signed a Memorandum of Understanding (MoU) to collaborate on increasing the number of clinical trials. By combining their expertise, both organizations will have the means to aid in the advancement of clinical research and medical services in response to the increased demand for quality and efficient clinical trials.

Rising R&D Investment Fueling Demand for Clinical Trial Support Services

Growing R&D Expenditure remains a key growth driver for the clinical trial support services market. Pharmaceutical, biopharmaceutical, and medical device companies are increasing their research and development budgets, particularly in oncology, rare diseases, and personalized medicine, resulting in a higher number of clinical trials and increased complexity. With the quantity of trial activity on the rise, there is an increased demand for site management, patient recruitment, data management and regulatory support, so sponsors are increasingly reliant on service providers with the expertise to deal with this burden. This trend is further influenced by global competition and increased compliance, creating an additional layer of outsourcing that grows the market for professional trial support services.

For instance, in June 2025, Gilead Sciences, Inc. reported a USD 32 billion investment to encourage U.S. biomedical research and innovation. This investment directed to clinical development, increasing the demand for trial support services.

For instance, in June 2025, AstraZeneca PLC announced a USD 1,94,03,408 investment to expand its Bengaluru research hub. This expansion will enhance the pharmaceutical organization's AI-powered R&D, expand centralized data analytics, develop infrastructure for clinical trials, and support it as the demand for leading global studies increases, as well as the demand for clinical trial support services, including patient recruitment, site management, and regulatory compliance.

AI and Digital Innovation Fuel Growth in Clinical Trial Support Services

Technological transformations, specifically artificial Intelligence (AI) and automation, play a crucial role in the growth of the market for clinical trial support services. Many AI-enabled tools have been developed to improve the execution of trials for several different tasks, including patient recruitment, selection of sites, study design and data monitoring. The large amount of data involved in trial execution can make it challenging to identify eligible populations; however, AI-enabled platforms can analyze massive datasets and identify eligible populations much more quickly than manual processes. This thereby improves trial execution efficiency and reduces the trial costs. Furthermore, digital solutions for trial execution, such as Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), eConsent, and remote monitoring, are making data collection and Sponsor communication easier than before. The rise of decentralized and hybrid trials has triggered a surge in the need for advanced technology solutions to improve the execution of clinical trials.

For instance, in January 2025, ICON plc expanded its AI tool portfolio to enhance clinical trial efficiency in areas such as study startup, document management, and resource forecasting. The initiative is led by ICON's AI Centre of Excellence, which focuses on accelerating trials and optimizing operations while ensuring ethical and data privacy standards.

For instance, in June 2024, IQVIA Holdings Inc. launched its "One Home" clinical trial technology platform, designed to address challenges faced by research sites and reduce operational overload. The platform entered beta testing and pilot phases, aiming to boost site capacity and streamline trial workflows through a unified, technology-driven approach.

Clinical Trial Site Management Dominates Clinical Trial Support Services Market

Clinical trial site management is the largest service segment in the global clinical trial support services market, as it is essential for facilitating the successful execution of clinical research. Most importantly, site management spans multiple areas, including identification of sites, completion of any required regulatory paperwork, site initiation, training staff, overseeing patient recruitment, and maintaining current operations, among others. Clinical trials (especially Phase II and Phase III trials) are becoming increasingly complex and geographically dispersed. This makes comprehensive and efficient site management essential. Well-managed clinical trial sites provide organizations with a means to confirm protocol compliance, ensure patient safety, facilitate the timely collection of data, and comply with regulatory obligations. Furthermore, a site's performance is directly associated with trial success; therefore, establishing and executing site management services is of utmost priority for pharmaceutical and biopharmaceutical sponsors.

For instance, in April 2025, Veeva Systems Inc. launched Veeva SiteVault CTMS, a unified clinical trial management system for research sites. The platform integrates with SiteVault eISF and eConsent, enabling sites to manage all aspects of a trial while seamlessly exchanging data with sponsors, significantly reducing manual processes and improving trial efficiency.

North America Dominates the Clinical Trial Support Services Market

North America continues to dominate the clinical trial support service market due to a substantial regional ecosystem of pharmaceutical, dynamic biotechnology, and clinical research organizations. North America is home to some of the largest and most influential clinical trial support services companies, including IQVIA Holdings Inc., Laboratory Corporation of America Holdings, and Thermo Fisher Scientific Inc., which provide comprehensive trial support services spanning the entire lifecycle, from protocol design and oversight to clinical logistics. In terms of impactful clinical trial support services, it is essential to note that the U.S. continues to have the most significant R&D spend; it also has a simplified regulatory environment under the supervision and direction of the U.S. Food and Drug Administration (FDA); in addition, the U.S. has access to a large, diverse patient population. Access to advanced healthcare infrastructure and technologies, such as artificial intelligence, real-world data platforms, and remote patient monitoring tools, further reinforces North America's position as a leader in the clinical trial support services market. Furthermore, North American companies lead in areas such as the development of decentralized and hybrid clinical trial models, offering a value proposition of greater efficiency, quicker recruitment, and increased patient access.

For instance, in December 2024, PPD, a subsidiary of Thermo Fisher Scientific Inc., extended two contracts with the U.S. National Institutes of Health (NIH) to provide ongoing oversight of clinical trial sites and research support services for HIV and related disease studies.

Impact of U.S. Tariffs on Global Clinical Trial Support Services Market

U.S. trade tariffs have significantly impacted the clinical trial support services industry, raising operational costs and creating disruptions in global supply chains. Tariffs on imported laboratory instruments, medical devices, and raw materials, particularly those originating from China, have led to an increase in expenses for contract research organizations (CROs) and trial sponsors. As a result of these issues, many companies are adopting a strategy of stocking up on supplies, shifting to domestic or nearby sources, and adjusting trial-related logistics to address tariff-related delays or undefined costs.

Key Players Landscape and Outlook

Competition in the market for clinical trial support services is increasing, as global CROs, mid-sized companies, and regional companies are competing for market share. Established companies are employing strategies that include acquisitions, globalized operations, strategic collaborations, and technology-based solutions to improve their service offerings. The increased use of decentralized and hybrid trials is evolving into more AI-based platforms, remote monitoring platforms, and digital trial management systems in response to the growing complexity of trials. Technological innovation is a key factor in how competitors compete. At the same time, regional and emerging market competitors (principally in Asia-Pacific and Latin America) have been making progress by developing cost-effective solutions that reflect local regulation and infrastructure conditions, providing a like-for-like service to larger competitors but offering price-competitive solutions.

For instance, in February 2024, Greenphire, Inc. acquired Clincierge-a concierge travel and logistics company serving clinical trial participants-to enhance its service offerings. This acquisition enables Greenphire to deliver more comprehensive patient support, streamline trial operations, and improve its competitive position in the global trial services landscape.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Clinical Trial Support Services Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Phase
    • 5.2.1.1. Phase I
    • 5.2.1.2. Phase II
    • 5.2.1.3. Phase III
    • 5.2.1.4. Phase IV
  • 5.2.2. By Service
    • 5.2.2.1. Clinical Trial Site Management
    • 5.2.2.2. Patient Recruitment Management
      • 5.2.2.2.1. Patient Recruitment and Registry Services
      • 5.2.2.2.2. Patient Retention
      • 5.2.2.2.3. Others
    • 5.2.2.3. Data Management
    • 5.2.2.4. Administrative Staff
    • 5.2.2.5. IRB
    • 5.2.2.6. Others
  • 5.2.3. By Sponsor
    • 5.2.3.1. Medical Device Companies
    • 5.2.3.2. Pharmaceutical and Biopharmaceutical Companies
    • 5.2.3.3. Others
  • 5.2.4. By Region
    • 5.2.4.1. North America
    • 5.2.4.2. Europe
    • 5.2.4.3. Asia-Pacific
    • 5.2.4.4. South America
    • 5.2.4.5. Middle East and Africa
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Phase
  • 5.3.2. By Service
  • 5.3.3. By Sponsor
  • 5.3.4. By Region

6. North America Clinical Trial Support Services Market Outlook, 2018-2032F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Phase
    • 6.2.1.1. Phase I
    • 6.2.1.2. Phase II
    • 6.2.1.3. Phase III
    • 6.2.1.4. Phase IV
  • 6.2.2. By Service
    • 6.2.2.1. Clinical Trial Site Management
    • 6.2.2.2. Patient Recruitment Management
      • 6.2.2.2.1. Patient Recruitment and Registry Services
      • 6.2.2.2.2. Patient Retention
      • 6.2.2.2.3. Others
    • 6.2.2.3. Data Management
    • 6.2.2.4. Administrative Staff
    • 6.2.2.5. IRB
    • 6.2.2.6. Others
  • 6.2.3. By Sponsor
    • 6.2.3.1. Medical Device Companies
    • 6.2.3.2. Pharmaceutical and Biopharmaceutical Companies
    • 6.2.3.3. Others
  • 6.2.4. By Country Share
    • 6.2.4.1. United States
    • 6.2.4.2. Canada
    • 6.2.4.3. Mexico
• 6.3. Country Market Assessment
  • 6.3.1. United States Clinical Trial Support Services Market Outlook, 2018-2032F*
    • 6.3.1.1. Market Size Analysis & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share Analysis & Forecast
  • 6.3.2. By Phase
    • 6.3.2.1. Phase I
    • 6.3.2.2. Phase II
    • 6.3.2.3. Phase III
    • 6.3.2.4. Phase IV
  • 6.3.3. By Service
    • 6.3.3.1. Clinical Trial Site Management
    • 6.3.3.2. Patient Recruitment Management
      • 6.3.3.2.1. Patient Recruitment and Registry Services
      • 6.3.3.2.2. Patient Retention
      • 6.3.3.2.3. Others
    • 6.3.3.3. Data Management
    • 6.3.3.4. Administrative Staff
    • 6.3.3.5. IRB
    • 6.3.3.6. Others
  • 6.3.4. By Sponsor
    • 6.3.4.1. Medical Device Companies
    • 6.3.4.2. Pharmaceutical and Biopharmaceutical Companies
    • 6.3.4.3. Others
  • 6.3.5. Canada
  • 6.3.6. Mexico

All segments will be provided for all regions and countries covered

7. Europe Clinical Trial Support Services Market Outlook, 2018-2032F

• 7.1. Germany
• 7.2. France
• 7.3. Italy
• 7.4. United Kingdom
• 7.5. Russia
• 7.6. Netherlands
• 7.7. Spain
• 7.8. Turkey
• 7.9. Poland

8. Asia-Pacific Clinical Trial Support Services Market Outlook, 2018-2032F

• 8.1. India
• 8.2. China
• 8.3. Japan
• 8.4. Australia
• 8.5. Vietnam
• 8.6. South Korea
• 8.7. Indonesia
• 8.8. Philippines

9. South America Clinical Trial Support Services Market Outlook, 2018-2032F

• 9.1. Brazil
• 9.2. Argentina

10. Middle East and Africa Clinical Trial Support Services Market Outlook, 2018-2032F

• 10.1. Saudi Arabia
• 10.2. UAE
• 10.3. South Africa

11. Demand Supply Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

• 15.1. Market Drivers
• 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Landscape and Innovation

18. Case Studies

19. Competitive Landscape

• 19.1. Competition Matrix of Top 5 Market Leaders
• 19.2. SWOT Analysis for Top 5 Players
• 19.3. Key Players Landscape for Top 10 Market Players
  • 19.3.1. Charles River Laboratories International, Inc.
    • 19.3.1.1. Company Details
    • 19.3.1.2. Key Management Personnel
    • 19.3.1.3. Products and Services
    • 19.3.1.4. Financials (As Reported)
    • 19.3.1.5. Key Market Focus and Geographical Presence
    • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 19.3.2. IQVIA Holdings Inc.
  • 19.3.3. WuXi AppTec Co., Ltd.
  • 19.3.4. Eurofins Scientific Limited
  • 19.3.5. ICON plc
  • 19.3.6. Syneos Health, Inc.
  • 19.3.7. Parexel International (MA) Corporation
  • 19.3.8. Laboratory Corporation of America Holdings
  • 19.3.9. Novo Nordisk A/S
  • 19.3.10. Thermo Fisher Scientific Inc. (PPD, Inc.)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer